LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 17

Search options

  1. Article ; Online: High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide.

    Rauth, Sabine / Hinz, Dominik / Börger, Michael / Uhrig, Markus / Mayhaus, Manuel / Riemenschneider, Matthias / Skerra, Arne

    The Biochemical journal

    2016  Volume 473, Issue 11, Page(s) 1563–1578

    Abstract: Amyloid beta (Aβ) peptides, in particular Aβ42 and Aβ40, exert neurotoxic effects and their overproduction leads to amyloid deposits in the brain, thus constituting an important biomolecular target for treatments of Alzheimer's disease (AD). We describe ... ...

    Abstract Amyloid beta (Aβ) peptides, in particular Aβ42 and Aβ40, exert neurotoxic effects and their overproduction leads to amyloid deposits in the brain, thus constituting an important biomolecular target for treatments of Alzheimer's disease (AD). We describe the engineering of cognate Anticalins as a novel type of neutralizing protein reagent based on the human lipocalin scaffold. Phage display selection from a genetic random library comprising variants of the human lipocalin 2 (Lcn2) with mutations targeted at 20 exposed amino acid positions in the four loops that form the natural binding site was performed using both recombinant and synthetic target peptides and resulted in three different Anticalins. Biochemical characterization of the purified proteins produced by periplasmic secretion in Escherichia coli revealed high folding stability in a monomeric state, with Tm values ranging from 53.4°C to 74.5°C, as well as high affinities for Aβ40, between 95 pM and 563 pM, as measured by real-time surface plasmon resonance analysis. The central linear VFFAED epitope within the Aβ sequence was mapped using a synthetic peptide array on membranes and was shared by all three Anticalins, despite up to 13 mutual amino acid differences in their binding sites. All Anticalins had the ability-with varying extent-to inhibit Aβ aggregation in vitro according to the thioflavin-T fluorescence assay and, furthermore, they abolished Aβ42-mediated toxicity in neuronal cell culture. Thus, these Anticalins provide not only useful protein reagents to study the molecular pathology of AD but they also show potential as alternative drug candidates compared with antibodies.
    MeSH term(s) Alzheimer Disease/drug therapy ; Alzheimer Disease/metabolism ; Amino Acid Sequence ; Amyloid beta-Peptides/antagonists & inhibitors ; Binding Sites ; Humans ; Lipocalins/chemistry ; Lipocalins/pharmacology ; Lipocalins/therapeutic use ; Molecular Sequence Data ; Peptide Library ; Protein Binding ; Protein Conformation ; Protein Engineering/methods
    Chemical Substances Amyloid beta-Peptides ; Lipocalins ; Peptide Library
    Language English
    Publishing date 2016-06-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 2969-5
    ISSN 1470-8728 ; 0006-2936 ; 0306-3275 ; 0264-6021
    ISSN (online) 1470-8728
    ISSN 0006-2936 ; 0306-3275 ; 0264-6021
    DOI 10.1042/BCJ20160114
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book ; Thesis: Identifizierung und Charakterisierung von gig-2, einem neuen durch Aktivität des muskarinischen Azetylcholinrezeptors, induzierten humanen Gen

    Mayhaus, Manuel

    2000  

    Author's details von Manuel Mayhaus
    Language German
    Size 72 S, Ill., graph. Darst
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Univ., Diss.--Hamburg, 2000
    Database Former special subject collection: coastal and deep sea fishing

    More links

    Kategorien

  3. Book ; Thesis: Identifizierung und Charakterisierung von gig-2, einem neuen durch Aktivität des muskarinischen Azetylcholinrezeptors, induzierten humanen Gen

    Mayhaus, Manuel

    2000  

    Author's details von Manuel Mayhaus
    Language German
    Size 72 S, Ill., graph. Darst
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Univ., Diss.--Hamburg, 2000
    Database Library catalogue of the German National Library of Science and Technology (TIB), Hannover

    More links

    Kategorien

  4. Article ; Online: Amyloid-β Protein Precursor Cleavage Products in Postmortem Ventricular Cerebrospinal Fluid of Alzheimer's Disease Patients.

    Hartl, Daniela / Gu, Wei / Mayhaus, Manuel / Pichler, Sabrina / Schöpe, Jakob / Wagenpfeil, Stefan / Riemenschneider, Matthias

    Journal of Alzheimer's disease : JAD

    2015  Volume 47, Issue 2, Page(s) 365–372

    Abstract: Accumulation and aggregation of amyloid-β (Aβ) are considered etiologic processes in Alzheimer's disease (AD). However, the roles of other AβPP cleavage products in disease pathology remain elusive. Here, we measured levels of the major secreted AβPP ... ...

    Abstract Accumulation and aggregation of amyloid-β (Aβ) are considered etiologic processes in Alzheimer's disease (AD). However, the roles of other AβPP cleavage products in disease pathology remain elusive. Here, we measured levels of the major secreted AβPP processing products sAβPPα, sAβPPβ, and Aβ species in postmortem collected ventricular CSF of 196 AD patients and 74 controls. In AD we identified Aβ₄₂ to decrease continuously with progressing Braak stages, whereas Aβ₄₀ was upregulated in early stages of the disease (Braak stage 4) and down-regulated with progressing pathology. Interestingly, both sAβPPα and sAβPPβ were upregulated in AD as compared to controls (sAβPPα, p = 0.02; sAβPPβ, p = 0.01). Moreover, we observed a strong positive correlation of both alternative AβPP processing products, sAβPPα and sAβPPβ (r²= 0.781; p <  0.0001). Together, our results argue for generally enhanced AβPP processing in AD patients and emphasize the necessity of analyzing the roles of all AβPP processing products in AD pathology.
    MeSH term(s) Aged ; Aged, 80 and over ; Alzheimer Disease/cerebrospinal fluid ; Alzheimer Disease/pathology ; Amyloid beta-Peptides/cerebrospinal fluid ; Amyloid beta-Protein Precursor/cerebrospinal fluid ; Disease Progression ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Male ; Peptide Fragments/cerebrospinal fluid
    Chemical Substances APP protein, human ; Amyloid beta-Peptides ; Amyloid beta-Protein Precursor ; Peptide Fragments ; amyloid beta-protein (1-40) ; amyloid beta-protein (1-42)
    Language English
    Publishing date 2015
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-150191
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster.

    Pichler, Sabrina / Gu, Wei / Hartl, Daniela / Gasparoni, Gilles / Leidinger, Petra / Keller, Andreas / Meese, Eckart / Mayhaus, Manuel / Hampel, Harald / Riemenschneider, Matthias

    Neurobiology of aging

    2017  Volume 50, Page(s) 167.e1–167.e10

    Abstract: MicroRNAs (miRNAs) are small noncoding RNA molecules, with essential functions in RNA silencing and post-transcriptional regulation of gene expression. miRNAs appear to regulate the development and function of the nervous system. Alterations of miRNA ... ...

    Abstract MicroRNAs (miRNAs) are small noncoding RNA molecules, with essential functions in RNA silencing and post-transcriptional regulation of gene expression. miRNAs appear to regulate the development and function of the nervous system. Alterations of miRNA expression have been associated with Alzheimer's disease (AD). To characterize the AD miRNA signature, we examined genome-wide miRNA and mRNA expression patterns in the temporal cortex of AD and control samples. We validated our miRNA results by semiquantitative real-time polymerase chain reaction (PCR) in independent prefrontal cortex. Furthermore, we separated gray and white matter brain sections to identify the cellular origin of the altered miRNA expression. We observed genome-wide downregulation of hsa-miR-132-3p and hsa-miR-212-3p in AD with a stronger decrease in gray matter AD samples. We further identified 10 differently expressed transcripts achieving genome-wide levels of significance. Significantly deregulated miRNAs and mRNAs were correlated and examined for potential binding sites (in silico). This miRNome-wide study in AD provides supportive evidence and corroborates an important contribution of miR-132/212 and corresponding target mRNAs to the pathogenesis of AD.
    MeSH term(s) Aged ; Aged, 80 and over ; Alzheimer Disease/genetics ; Binding Sites ; Down-Regulation ; Female ; Gene Expression ; Genome-Wide Association Study ; Gray Matter/metabolism ; Humans ; Male ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Multigene Family/genetics
    Chemical Substances MIRN132 microRNA, human ; MIRN212 microRNA, human ; MicroRNAs
    Language English
    Publishing date 2017
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 604505-4
    ISSN 1558-1497 ; 0197-4580
    ISSN (online) 1558-1497
    ISSN 0197-4580
    DOI 10.1016/j.neurobiolaging.2016.09.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Rare

    May, Patrick / Pichler, Sabrina / Hartl, Daniela / Bobbili, Dheeraj R / Mayhaus, Manuel / Spaniol, Christian / Kurz, Alexander / Balling, Rudi / Schneider, Jochen G / Riemenschneider, Matthias

    Neurology. Genetics

    2018  Volume 4, Issue 2, Page(s) e224

    Abstract: Objective: The aim of this study was to identify variants associated with familial late-onset Alzheimer disease (AD) using whole-genome sequencing.: Methods: Several families with an autosomal dominant inheritance pattern of AD were analyzed by whole- ...

    Abstract Objective: The aim of this study was to identify variants associated with familial late-onset Alzheimer disease (AD) using whole-genome sequencing.
    Methods: Several families with an autosomal dominant inheritance pattern of AD were analyzed by whole-genome sequencing. Variants were prioritized for rare, likely pathogenic variants in genes already known to be associated with AD and confirmed by Sanger sequencing using standard protocols.
    Results: We identified 2 rare
    Conclusions: We conclude that both SNVs might contribute to the development of AD in the examined family members. Together with previous findings, our data confirm
    Language English
    Publishing date 2018-03-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2818607-2
    ISSN 2376-7839
    ISSN 2376-7839
    DOI 10.1212/NXG.0000000000000224
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease.

    Hartl, Daniela / May, Patrick / Gu, Wei / Mayhaus, Manuel / Pichler, Sabrina / Spaniol, Christian / Glaab, Enrico / Bobbili, Dheeraj Reddy / Antony, Paul / Koegelsberger, Sandra / Kurz, Alexander / Grimmer, Timo / Morgan, Kevin / Vardarajan, Badri N / Reitz, Christiane / Hardy, John / Bras, Jose / Guerreiro, Rita / Balling, Rudi /
    Schneider, Jochen G / Riemenschneider, Matthias

    Molecular psychiatry

    2018  Volume 25, Issue 3, Page(s) 629–639

    Abstract: Common variants of about 20 genes contributing to AD risk have so far been identified through genome-wide association studies (GWAS). However, there is still a large proportion of heritability that might be explained by rare but functionally important ... ...

    Abstract Common variants of about 20 genes contributing to AD risk have so far been identified through genome-wide association studies (GWAS). However, there is still a large proportion of heritability that might be explained by rare but functionally important variants. One of the so far identified genes with rare AD causing variants is ADAM10. Using whole-genome sequencing we now identified a single rare nonsynonymous variant (SNV) rs142946965 [p.R215I] in ADAM17 co-segregating with an autosomal-dominant pattern of late-onset AD in one family. Subsequent genotyping and analysis of available whole-exome sequencing data of additional case/control samples from Germany, UK, and USA identified five variant carriers among AD patients only. The mutation inhibits pro-protein cleavage and the formation of the active enzyme, thus leading to loss-of-function of ADAM17 alpha-secretase. Further, we identified a strong negative correlation between ADAM17 and APP gene expression in human brain and present in vitro evidence that ADAM17 negatively controls the expression of APP. As a consequence, p.R215I mutation of ADAM17 leads to elevated Aß formation in vitro. Together our data supports a causative association of the identified ADAM17 variant in the pathogenesis of AD.
    MeSH term(s) ADAM17 Protein/genetics ; ADAM17 Protein/metabolism ; Aged ; Alzheimer Disease/genetics ; Amyloid Precursor Protein Secretases/metabolism ; Amyloid beta-Protein Precursor/genetics ; Case-Control Studies ; Female ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Germany ; Humans ; Loss of Function Mutation/genetics ; Male ; Middle Aged ; Mutation ; Whole Exome Sequencing
    Chemical Substances Amyloid beta-Protein Precursor ; Amyloid Precursor Protein Secretases (EC 3.4.-) ; ADAM17 Protein (EC 3.4.24.86) ; ADAM17 protein, human (EC 3.4.24.86)
    Language English
    Publishing date 2018-07-09
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1330655-8
    ISSN 1476-5578 ; 1359-4184
    ISSN (online) 1476-5578
    ISSN 1359-4184
    DOI 10.1038/s41380-018-0091-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Temporal gene expression profile of the hippocampus following trace fear conditioning.

    Sirri, Alessandra / Bianchi, Veronica / Pelizzola, Mattia / Mayhaus, Manuel / Ricciardi-Castagnoli, Paola / Toniolo, Daniela / D'Adamo, Patrizia

    Brain research

    2009  Volume 1308, Page(s) 14–23

    Abstract: In this paper we report the results of gene expression profiling of C57Bl/6N mice hippocampus after trace fear conditioning (TFC), and the identification of genes regulated at early and late steps after conditioning. Several of the genes regulated at ... ...

    Abstract In this paper we report the results of gene expression profiling of C57Bl/6N mice hippocampus after trace fear conditioning (TFC), and the identification of genes regulated at early and late steps after conditioning. Several of the genes regulated at early steps following TFC appeared common to many training protocols. At later stages (2 and 6 h), most of the genes identified were different from those identified following other learning paradigms resulting in memory consolidation. At 6 h after training, few genes were upregulated in respect to the naïve condition, suggesting that many gene products have eventually to be downregulated to achieve stable synapses modification and memory formation. In conclusion, the results presented highlight a number of genes whose expression is specifically modified in the mouse hippocampus following TFC and demonstrate the specificity associated to different forms of conditioning.
    MeSH term(s) Animals ; Conditioning, Classical/physiology ; Fear ; Gene Expression/genetics ; Gene Expression Profiling ; Hippocampus/metabolism ; Male ; Memory/physiology ; Mice ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Time Factors ; Up-Regulation/genetics
    Chemical Substances RNA, Messenger
    Language English
    Publishing date 2009-10-24
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1200-2
    ISSN 1872-6240 ; 0006-8993
    ISSN (online) 1872-6240
    ISSN 0006-8993
    DOI 10.1016/j.brainres.2009.10.049
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The Genopolis Microarray Database

    Splendiani Andrea / Brandizi Marco / Even Gael / Beretta Ottavio / Pavelka Norman / Pelizzola Mattia / Mayhaus Manuel / Foti Maria / Mauri Giancarlo / Ricciardi-Castagnoli Paola

    BMC Bioinformatics, Vol 8, Iss Suppl 1, p S

    2007  Volume 21

    Abstract: Abstract Background Gene expression databases are key resources for microarray data management and analysis and the importance of a proper annotation of their content is well understood. Public repositories as well as microarray database systems that can ...

    Abstract Abstract Background Gene expression databases are key resources for microarray data management and analysis and the importance of a proper annotation of their content is well understood. Public repositories as well as microarray database systems that can be implemented by single laboratories exist. However, there is not yet a tool that can easily support a collaborative environment where different users with different rights of access to data can interact to define a common highly coherent content. The scope of the Genopolis database is to provide a resource that allows different groups performing microarray experiments related to a common subject to create a common coherent knowledge base and to analyse it. The Genopolis database has been implemented as a dedicated system for the scientific community studying dendritic and macrophage cells functions and host-parasite interactions. Results The Genopolis Database system allows the community to build an object based MIAME compliant annotation of their experiments and to store images, raw and processed data from the Affymetrix GeneChip ® platform. It supports dynamical definition of controlled vocabularies and provides automated and supervised steps to control the coherence of data and annotations. It allows a precise control of the visibility of the database content to different sub groups in the community and facilitates exports of its content to public repositories. It provides an interactive users interface for data analysis: this allows users to visualize data matrices based on functional lists and sample characterization, and to navigate to other data matrices defined by similarity of expression values as well as functional characterizations of genes involved. A collaborative environment is also provided for the definition and sharing of functional annotation by users. Conclusion The Genopolis Database supports a community in building a common coherent knowledge base and analyse it. This fills a gap between a local database and a public repository, where the ...
    Keywords Computer applications to medicine. Medical informatics ; R858-859.7 ; Biology (General) ; QH301-705.5
    Subject code 004
    Language English
    Publishing date 2007-03-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors.

    Martinelli-Boneschi, Filippo / Giacalone, Giacomo / Magnani, Giuseppe / Biella, Gloria / Coppi, Elisabetta / Santangelo, Roberto / Brambilla, Paola / Esposito, Federica / Lupoli, Sara / Clerici, Francesca / Benussi, Luisa / Ghidoni, Roberta / Galimberti, Daniela / Squitti, Rosanna / Confaloni, Annamaria / Bruno, Giuseppe / Pichler, Sabrina / Mayhaus, Manuel / Riemenschneider, Matthias /
    Mariani, Claudio / Comi, Giancarlo / Scarpini, Elio / Binetti, Giuliano / Forloni, Gianluigi / Franceschi, Massimo / Albani, Diego

    Neurobiology of aging

    2013  Volume 34, Issue 6, Page(s) 1711.e7–13

    Abstract: We conducted a genome-wide association study in a cohort of 176 Italian Alzheimer's disease (AD) patients with extreme phenotype of response to cholinesterase inhibitors. Patients were classified into responders in case of positive, stable, or ≤1 ... ...

    Abstract We conducted a genome-wide association study in a cohort of 176 Italian Alzheimer's disease (AD) patients with extreme phenotype of response to cholinesterase inhibitors. Patients were classified into responders in case of positive, stable, or ≤1 worsening of mini-mental state examination score and into nonresponders if >3 points worsening during a median follow-up of 0.85 years of treatment. Forty-eight single-nucleotide polymorphisms were selected for replication in 198 additional AD-treated patients. By using the dichotomous response trait and a quantitative trait approach (change of mini-mental state examination), a nominal replication and evidence of association when combining data were achieved for 2 single-nucleotide polymorphisms associated with response to treatment: rs6720975A (pcombined = 2.9 × 10(-5), beta regression coefficient: 1.61) and rs17798800A (pcombined = 6.8 × 10(-6), odds ratio = 0.38, 95% confidence interval = 0.25-0.58). Rs6720975 maps in the intronic region of PRKCE, a protein kinase involved in several cellular functions, whereas rs17798800 is intergenic and, according to expression quantitative trait locus (eQTL) analysis, it acts as a cis-regulator of NBEA, an A kinase-anchoring protein playing a substantial role in the maturation of the nervous system. Despite its limitations, this project paves the way for the application of personalized medicine in AD patients and for collaborative efforts in this field.
    MeSH term(s) Aged ; Aged, 80 and over ; Alzheimer Disease/diagnosis ; Alzheimer Disease/drug therapy ; Alzheimer Disease/genetics ; Cholinesterase Inhibitors/therapeutic use ; Cohort Studies ; Female ; Follow-Up Studies ; Genome-Wide Association Study/methods ; Humans ; Male ; Pharmacogenetics ; Polymorphism, Single Nucleotide/genetics
    Chemical Substances Cholinesterase Inhibitors
    Language English
    Publishing date 2013-06
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 604505-4
    ISSN 1558-1497 ; 0197-4580
    ISSN (online) 1558-1497
    ISSN 0197-4580
    DOI 10.1016/j.neurobiolaging.2012.12.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top